Spiich Labs raises €600k pre-seed for AI sales agents

Spiich Labs, a Stockholm-based company building an agentic AI platform for B2B sales teams, has raised €600k in pre-seed funding. The round, announced on 12 November 2025, is led by Ampli Ventures, with backing from Tandem Health CEO Lukas Saari, Creandum co-founder Stefan Lindeberg, Neo4j founder Emil Eifrem, one of the founders of Lovable, and OpenAI’s head of startups in Europe.

Founded in 2025 by Johan Torssell and Dennis Hadzialic, Spiich builds AI agents that handle the work around selling. Reps update their CRM by speaking or typing in natural language. Spiich works out which record they mean and writes structured data: deal stages, notes, contacts, activities, custom fields. Agents prepare briefs before meetings, draft follow-ups afterwards, research and qualify prospects, and run in the background on schedules or CRM triggers. The platform integrates natively with HubSpot, Attio and Pipedrive.

The 22% problem

The premise is simple: selling is time spent with customers, and most of the rest can be automated.

The numbers back the diagnosis. Salesforce’s 2026 State of Sales report, the 7th edition of the survey, polled 4,050 sales professionals and found that reps spend just 22% of the workweek meeting with customers. The remaining 78% goes to prospecting, creating quotes, planning, manual data entry and training. Spiich frames the same problem in its own terms: 65% of sales time lost to non-selling activities, which the company estimates as a €300 billion global drag on productivity.

CRM hygiene sits at the centre of that lost time. Data entry is the task reps resent most and skip first, which then degrades pipeline visibility and forecasting for everyone above them. Spiich’s bet is that an agent which writes clean, structured records from a voice note removes the trade-off between rep time and data quality.

Inside the round

Torssell says he turned down a role at Palantir to start the company, after watching startup founders and their sales teams lose entire days to admin work that could be automated. Four months in, Spiich reports customers across five countries and is targeting B2B SaaS teams with 20 to 200 reps.

The investor list is worth a closer look. Ampli Ventures leads, but the angel line-up reads like a map of the current Nordic AI wave: the CEO of Tandem Health, which builds AI scribes for clinicians, a Creandum co-founder, the founder of graph database company Neo4j, a Lovable founder, and an OpenAI executive. Eifrem’s stated reason for backing the company is architectural. In his words, the team has “rebuilt sales software from first principles for AI” rather than attaching automation to legacy systems.

The capital will fund deeper CRM integrations, proactive intelligence features, and a push to reach 2,000 sales professionals by the end of 2026.

What to watch

Three questions will determine how far €600k takes Spiich. First, incumbent response: Salesforce, HubSpot and the new generation of CRMs like Attio are all shipping their own AI agents, so Spiich needs to prove that a dedicated, CRM-agnostic layer beats a native feature. Second, retention: voice-to-CRM tools live or die on whether reps still use them in month six, once the novelty fades. Third, the path from assistant to platform: the pre-seed pitch is admin removal, but the valuation story investors are buying is an ecosystem of agents sharing context across the full sales workflow.

For Sesamers readers tracking European AI rounds, Spiich fits a clear 2025 pattern: small, fast pre-seeds backed by operator angels rather than institutional funds alone, aimed at rebuilding one professional workflow around agents. EU-Startups counted roughly €7 million in disclosed 2025 funding across four European startups automating sales operations, including Bizzy in Belgium and Genial in France. The category is getting crowded early. Spiich’s angel bench and its four-month traction give it a credible start, and the next 12 months of retention data will tell us whether the wedge holds.